MAP2K7 and melanoma: Due to its downstream signaling to the MAPK pathway and the knowledge that BRAF inhibitors lead to enhanced growth of BRAFwt melanomas, several trials investigated the efficiency of MEK inhibition in this subset of melanoma [29].